Francois Jean Formela

Affiliations

  • at Korro Bio Inc. (KRRO), 2025-06-12
  • at Ikena Oncology Inc. (IKNA), 2024-06-10
  • Director at Intellia Therapeutics Inc. (NTLA), 2022-06-16
  • Director at Translate Bio Inc. (TBIO), 2021-09-14
  • Director at Spero Therapeutics Inc. (SPRO), 2021-08-18
  • Large Shareholder, Director at Egalet Corp (EGLT), 2014-02-12
  • Large Shareholder, Director at Arca Biopharma Inc. (ABIO), 2012-10-25
  • Large Shareholder, Director at Horizon Pharma Inc. (HZNP), 2012-03-06
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
IKNA $16.00 125,000 $2,000,000.00 874,634 2021-03-30 Filing
SPRO $14.00 428,571 $5,999,994.00 2,408,128 2017-11-06 Filing
EGLT $12.00 41,667 $500,004.00 2,152,222 2014-02-11 Filing
HZNP $3.62 828,443 $2,999,957.79 3,688,294 2012-03-02 Filing
HZNP $9.00 10,782 $97,038.00 2,533,327 2011-08-02 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
IKNA $14.00 5,959 $83,426.00 1,241,935 2021-12-14 Filing
IKNA $14.64 8,330 $121,951.20 1,247,894 2021-12-13 Filing
IKNA $15.03 11,989 $180,194.67 1,256,224 2021-12-10 Filing
TBIO $38.00 2,055,063 $78,092,394.00 0 2021-09-14 Filing
NTLA $143.45 6,149 $882,074.05 10,000 2021-06-28 Filing